ethylisopropylamiloride has been researched along with Colorectal Neoplasms in 1 studies
ethylisopropylamiloride: structure in first source
ethylisopropylamiloride : A member of the class of pyrazines that is amiloride in which the amino substitutent of the pyrazine ring that is adjacent to the chloro substituent has been substituted by an ethyl group and by an isopropyl group.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Serafino, A | 1 |
| Moroni, N | 1 |
| Psaila, R | 1 |
| Zonfrillo, M | 1 |
| Andreola, F | 1 |
| Wannenes, F | 1 |
| Mercuri, L | 1 |
| Rasi, G | 1 |
| Pierimarchi, P | 1 |
1 other study available for ethylisopropylamiloride and Colorectal Neoplasms
| Article | Year |
|---|---|
Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signaling.
Topics: Adenocarcinoma; Amiloride; Animals; Atrial Natriuretic Factor; beta Catenin; Breast Neoplasms; Cell | 2012 |